FDA tells White House to scale back plans to offer boost shots

FDA wants more time to review data

The New York Times reports that officials have told the White House to scale back plans to offer covid booster shots to the general public by Sept 20.

The FDA warned it might only recommend boosters for Pfizer vaccine recipients and possibly only some of them to start. On Moderna, the report says this:

Among the reasons for delaying is that regulators need more time to
decide the proper dosage for a possible third Moderna shot. The
company’s application asking the F.D.A. to authorize a booster shot
contains insufficient data, one federal official familiar with the
process said.

The FDA hasn’t received the raw data from Israel, which is already delivering third doses to everyone.

Invest in yourself. See our forex education hub.

Articles You May Like

USD/JPY drops below 135.00, eyes 200-day moving average
US dollar index (DXY) bounces of the 200 day MA yesterday.
Sam Bankman-Fried reveals the circumstances behind Bahamian withdrawals
Major US stock indices open mixed
FTX resumes employee and contractor payments after weeks in limbo

Leave a Reply

Your email address will not be published. Required fields are marked *